Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries Medical Dialogues Bureau11 April 2020 4:00 AM GMTParis: French pharma major Sanofi said on Friday it has decided to donate 100 million doses of hydroxychloroquine, the anti-malaria drug which could...
Trump has small financial interest in French pharma giant that makes hydroxychloroquine: NYT Medical Dialogues Bureau9 April 2020 4:30 AM GMTNew York: President Donald Trump, who has aggressively promoted the use of hydroxychloroquine to treat coronavirus patients in and has asked India to...
Sanofi delays Slump Sale and transfer of Ankleshwar plant Medical Dialogues Bureau30 March 2020 10:00 AM GMTGujrat: Sanofi has announced the change in date for the closing of a transaction relating to Slump Sale and transfer of its manufacturing facility of...
Ibuprofen and Covid-19: Drugmaker Sanofi defends Molecule, WHO updates its stand Medical Dialogues Bureau21 March 2020 8:05 AM GMTNew Delhi: Responding to the World Health Organisation statement earlier that recommended avoidance of Ibuprofen due to its suspected worserning...
Regeneron, Sanofi begin testing use of Arthritis Drug Kevzara to treat COVID-19 Medical Dialogues Bureau18 March 2020 6:54 AM GMTKevzara is a fully-human monoclonal antibody that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor.The use of...
Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi Medical Dialogues Bureau12 March 2020 5:59 AM GMTInsulin Glargine is a long-acting insulin used to treat adults with Type 2 diabetes and adults and paediatric patients with Type 1 diabetes for the...
Sanofi gets USFDA nod for Sarclisa (isatuximab-irfc) for refractory multiple myeloma Medical Dialogues Bureau4 March 2020 6:41 AM GMTSarclisa offers an intravenous (IV) administration and is dosed at 10 mg/kg, in combination with pom-dex, every week for four weeks and then every two...
Sanofi to pay USD 11.9 million to resolve US drug charity kickback probe Medical Dialogues Bureau2 March 2020 6:35 AM GMTSanofi SA has agreed to pay $11.85 million to resolve U.S. allegations that it used a charity that helps cover Medicare patients' out-of-pocket drug...
More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs Medical Dialogues Bureau2 Jan 2020 9:18 AM GMTNew Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA Medical Dialogues Bureau2 Nov 2019 4:00 AM GMTZantac sold over-the-counter in the United States by French drugmaker Sanofi SA, and some of its generic versions, have been recalled due to possible...
Landmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percent Medical Dialogues Bureau1 Nov 2019 9:59 AM GMTScale-up of affordable Rifapentine stands to benefit over a million people in India alone, where more people suffer from TB than anywhere else in the...
No carcinogen found in alternatives of heart burn drug Zantac, generics: USFDA Medical Dialogues Bureau24 Oct 2019 3:50 AM GMTEarly tests of alternatives to over-the-counter ranitidine, such as Pepcid, Tagamet, Nexium, Prevacid and Prilosec show no NDMA, the agency said.New...